3Eisen T,Bukowski RM,Staehler M,et al.Randomized phaseⅢtrial of sorafenib in advanced renal cell carcinoma(RCC):Impact of crossover on survival[J].J clin oncol,2006,24(18s):4524.
4Robert C,Soria JC,Spatz A,et al.Cutaneous side-effects of kinase inhibitors and blocking antibodiesLancet[J].Lancet Oncol,2005,6(7):491-500.
5Escudier B,Szczylik C,Eisen T,et al.Randomized PhaseⅢtrial of the Raf kinase and VEGFR inhibitor sorafenib(BAY43-9006)in patients with advanced renal cell carcinoma[J].Eur J Cancer Supplements,2005,3(2):226.
10Mego M, Reckova M, Obertova J, et al. Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell careinoma[J].Ann Oncol, 2007,18(11): 1906-1907.
